PXRB logo

PixarBio OTCPK:PXRB Stock Report

Last Price

US$0.000001

Market Cap

US$81.0

7D

0%

1Y

n/a

Updated

24 Sep, 2023

Data

Company Financials

PXRB Stock Overview

PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain.

PXRB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

PixarBio Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PixarBio
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.000001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

PXRBUS BiotechsUS Market
7D0%-0.06%2.1%
1Yn/a9.8%30.4%

Return vs Industry: Insufficient data to determine how PXRB performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how PXRB performed against the US Market.

Price Volatility

Is PXRB's price volatile compared to industry and market?
PXRB volatility
PXRB Average Weekly Movementn/a
Biotechs Industry Average Movement11.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: PXRB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PXRB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aFrank Reynoldshttps://www.pixarbio.com

PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson’s disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models.

PixarBio Corporation Fundamentals Summary

How do PixarBio's earnings and revenue compare to its market cap?
PXRB fundamental statistics
Market capUS$81.00
Earnings (TTM)-US$12.19m
Revenue (TTM)US$7.50k

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PXRB income statement (TTM)
RevenueUS$7.50k
Cost of RevenueUS$0
Gross ProfitUS$7.50k
Other ExpensesUS$12.20m
Earnings-US$12.19m

Last Reported Earnings

Sep 30, 2016

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did PXRB perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.